Do we not nuderstand YET that this is an OPEN trial! No data is hidden other than time it takes to process pharmacokinetics. HAM-D , Cogstate, Neuronetrix, Ariana, EEG, for over 2 years for some patients..
The question of the day..
Isn't whether or not the data will be good enough for SOC,,because that's all we need to be a Multi Billion Dollar enterprise.. the question in my mind is do we have enough data to convince more than one BP to in license A2-73?
I am already sold on Anavex will try to accumulate through 1st Billion in Market cap..but what would bring down the house in cheers would be if; a big IF: some dual therapy patients went Mono Therapy at 6 months and these patients responded like the other 7 Mono therapy patients..
I would like to think Ariana could bank that data for Anavex..
It's going to be a restless week..
But 9 month data should put all longs at rest.. long term we are strong..
very strong!